Patents by Inventor Akira Asakura

Akira Asakura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7842483
    Abstract: The present invention is directed to a novel cytochrome c oxidase complex, genetic materials useful for the preparation of the said complex, such as recombinant polypeptides involved in cytochrome c oxidase complex, recombinant DNA fragments, expression vectors, recombinant organisms and the like. Those novel cytochrome c oxidase complex and genetic materials may be originated from a microorganism having the identifying characteristics of Gluconobacter oxydans DSM 4025. The present invention also provides a method for the preparation of the said novel recombinant cytochrome c oxidase complex and a process for the production of 2-keto-L-gulonic acid (2KGA).
    Type: Grant
    Filed: January 26, 2005
    Date of Patent: November 30, 2010
    Assignee: DSM Nutritional Products, Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh
  • Publication number: 20050123989
    Abstract: The present invention is directed to a novel cytochrome c oxidase complex, genetic materials useful for the preparation of the said complex, such as recombinant polypeptides involved in cytochrome c oxidase complex, recombinant DNA fragments, expression vectors, recombinant organisms and the like. Those novel cytochrome c oxidase complex and genetic materials may be originated from a microorganism having the identifying characteristics of Gluconobacter oxydans DSM 4025. The present invention also provides a method for the preparation of the said novel recombinant cytochrome c oxidase complex and a process for the production of 2-keto-L-gulonic acid (2KGA).
    Type: Application
    Filed: January 26, 2005
    Publication date: June 9, 2005
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh
  • Publication number: 20050090645
    Abstract: The present invention is directed to a recombinant enzymes having alcohol and aldehyde dehydrogenase activity which comprises one or more recombinant polypeptides selected from the group consisting of polypeptides which are identified by SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8 and chimeric recombinant polypeptides that are a chimeric combination of at least two of the following amino acid sequences identified by SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8 and functional derivatives of the polypeptides identified above which contain addition, insertion, deletion and/or substitution of one or more amino acid residues, wherein said enzymatic polypeptides have said alcohol and aldehyde dehydrogenase activity. DNA molecules encoding the recombinant polypeptides, vectors comprising such DNA molecules, host cells transformed by such vectors and processes for the production of such recombinant enzymes are provided.
    Type: Application
    Filed: March 17, 2004
    Publication date: April 28, 2005
    Inventors: Akira Asakura, Tatsuo Hoshino, Setsuko Ojima, Masako Shinjoh, Noribumi Tomiyama
  • Patent number: 6869785
    Abstract: The present invention is directed to a novel cytochrome c oxidase complex, genetic materials useful for the preparation of the said complex, such as recombinant polypeptides involved in cytochrome c oxidase complex, recombinant DNA fragments, expression vectors, recombinant organisms and the like. Those novel cytochrome c oxidase complex and genetic materials may be originated from a microorganism having the identifying characteristics of Gluconobacter oxydans DSM 4025. The present invention also provides a method for the preparation of the said novel recombinant cytochrome c oxidase complex and a process for the production of 2-keto-L-gulonic acid (2KGA).
    Type: Grant
    Filed: November 14, 2000
    Date of Patent: March 22, 2005
    Assignee: DSM Nutritional Products, Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh
  • Patent number: 6777212
    Abstract: A process for producing L-ascorbic acid or D-erythorbic acid, or in each case its sodium, potassium or calcium salt, from 2-keto-L-gulonic acid or 2-keto-D-gluconic acid, or in each case its sodium, potassium or calcium salt, that involves incubating 2-keto-L-gulonic acid or 2-keto-D-gluconic acid, each as the free acid or as its sodium, potassium or calcium salt, and the cells of a thermoacidophilic microorganism at temperatures from about 30° C. to about 100° C., and at a pH from about 1 to about 6, in a solution, to form L-ascorbic acid or D-erythorbic acid or an appropriate salt thereof, and isolating said product from the solution.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: August 17, 2004
    Assignee: Roche Vitamins, Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh
  • Publication number: 20040137009
    Abstract: A novel human IFN-&agr; subtype and its derivative having an unprecedentedly high specific activity, DNA encoding these proteins, an expression vector having said DNA, a transformant transformed with said expression vector, a method of producing the above human IFN-&agr; and its derivative, and medical uses of the above human IFN-&agr; and its derivative.
    Type: Application
    Filed: January 15, 2004
    Publication date: July 15, 2004
    Applicant: SUMITOMO PHARMACEUTICALS COMPANY LIMITED
    Inventors: Shin-ichi Kojima, Akira Asakura, Tetsuaki Futatsugi, Yuko Ota, Yuki Fukuda, Shinsuke Sagara
  • Patent number: 6730503
    Abstract: The present invention is directed to a recombinant enzymes having alcohol and aldehyde dehydrogenase activity which comprises one or mom recombinant polypeptides selected from the group consisting of polypeptides which are identified by SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8 and chimeric recombinant polypeptides that are a chimeric combination of at least two of the following amino acid sequences identified by SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8 and functional derivatives of the polypeptides identified above which contain addition, insertion, deletion and/or substitution of one or more amino acid residues, wherein said enzymatic polypeptides have said alcohol and aldehyde dehydrogenase activity. DNA molecules encoding the recombinant polypeptides, vectors comprising such DNA molecules, host cells transformed by such vectors and processes for the production of such recombinant enzymes are provided.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: May 4, 2004
    Assignee: Roche Vitamins Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Setsuko Ojima, Masako Shinjoh, Noribumi Tomiyama
  • Publication number: 20040063166
    Abstract: The present invention provides processes for making biotin from desthiobiotin by either contacting desthiobiotin with an enzyme reaction mixture containing bioB gene product and nifU gene product and/or nifS gene product and isolating the biotin or cultivating a microorganism transformed with DNA encoding the bioB gene product, nifU gene product and nifS gene product and isolating the biotin.
    Type: Application
    Filed: May 15, 2003
    Publication date: April 1, 2004
    Applicant: ROCHE VITAMINS, INC.
    Inventors: Tatsuo Hoshino, Akira Asakura, Tatsuya Kiyasu, Yoshie Nagahashi
  • Patent number: 6703225
    Abstract: A novel human IFN-&agr; subtype and its derivative having an unprecedentedly high specific activity, DNA encoding these proteins, an expression vector having said DNA, a transformant transformed with said expression vector, a method of producing the above human IFN-&agr; and its derivative, and medical uses of the above human IFN-&agr; and its derivative.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: March 9, 2004
    Assignee: Sumitomo Pharmaceuticals Company, Limited
    Inventors: Shin-ichi Kojima, Akira Asakura, Tetsuaki Futatsugi, Yuko Ota, Yuki Fukuda, Shinsuke Sagara
  • Publication number: 20030105160
    Abstract: A process for producing L-ascorbic acid or D-erythorbic acid, or in each case its sodium, potassium or calcium salt, from 2-keto-L-gulonic acid or 2-keto-D-gluconic acid, or in each case its sodium, potassium or calcium salt, that involves incubating 2-keto-L-gulonic acid or 2-keto-D-gluconic acid, each as the free acid or as its sodium, potassium or calcium salt, and the cells of a thermoacidophilic microorganism at temperatures from about 30° C. to about 100° C., and at a pH from about 1 to about 6, in a solution, to form L-ascorbic acid or D-erythorbic acid or an appropriate salt thereof, and isolating said product from the solution.
    Type: Application
    Filed: August 23, 2001
    Publication date: June 5, 2003
    Applicant: ROCHE VITAMINS INC.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh
  • Publication number: 20030096382
    Abstract: The present invention provides process for making biotin from desthiobiotin either contacting desthiobiotin with an enzyme reaction mixture containing bioB gene product and nifU gene product and/or nifS gene product and isolating the biotin or cultivating a microorganism transformed with DNA encoding the bioB gene product, nifU gene product and nifS gene product and isolating the biotin.
    Type: Application
    Filed: March 22, 2001
    Publication date: May 22, 2003
    Applicant: ROCHE VITAMINS INC.
    Inventors: Tatsuo Hoshino, Akira Asakura, Tatsuya Kiyasu, Yoshie Nagahashi
  • Patent number: 6407203
    Abstract: This invention is directed to cytochrome c551 polypeptides and polynucleotides encoding the polypeptides.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: June 18, 2002
    Assignee: Roche Vitamins, Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh, Noribumi Tomiyama
  • Patent number: 6361978
    Abstract: The present invention provides processes for making biotin from desthiobiotin by either contacting desthiobiotin with an enzyme reaction mixture containing bioB gene product and nifU gene product and/or nifS gene product and isolating the biotin or cultivating a microorganism transformed with DNA encoding the bioB gene product, nifU gene product and nifS gene product and isolating the biotin.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: March 26, 2002
    Assignee: Roche Vitamins, Inc.
    Inventors: Tatsuo Hoshino, Akira Asakura, Tatsuya Kiyasu, Yoshie Nagahashi
  • Patent number: 6146860
    Abstract: A process for producing L-ascorbic acid (vitamin C) from 2-keto-L-gulonic acid or D-erythorbic acid from 2-keto-D-gluconic acid by contacting 2-keto-L-gulonic acid or 2-keto-D-gluconic acid, respectively, in solution with a lactonase, particularly one belonging to the enzyme class EC 3.1.1.x, according to the classification of Enzyme Nomenclature. The solvent for this reaction can be water, an aqueous alcohol, a non-alcoholic organic solvent or a mixture of an aqueous alcohol and a non-alcoholic organic solvent. The contacting is generally performed in a temperature range of 0.degree. C. to 120.degree. C. and a pH range of 1.5 to 12. In each case the starting material can be in the form of the free acid, the sodium salt, or the calcium salt. The so-produced vitamin C has very well known uses, and the alternatively produced D-erythorbic acid is useful as an antioxidant for food additives.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: November 14, 2000
    Assignee: Roche Vitamins Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Tatsuya Kiyasu, Masako Shinjoh
  • Patent number: 6037147
    Abstract: This invention is directed to cytochrome c.sub.551 polypeptides and polynucleotides encoding the polypeptides.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: March 14, 2000
    Assignee: Roche Vitamins Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino, Masako Shinjoh, Noribumi Tomiyama
  • Patent number: 5932463
    Abstract: The present invention relates to a novel alcohol/aldehyde dehydrogenase (hereinafter referred to as AADH), a process for producing the same and a process for producing aldehydes, carboxylic acids and ketones, especially 2-keto-L-gulonic acid (hereinafter referred to as 2-KGA) utilizing said enzyme.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: August 3, 1999
    Assignee: Roche Vitamins Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino
  • Patent number: 5916785
    Abstract: The present invention relates to a novel alcohol/aldehyde dehydro-genase (hereinafter referred to as AADH), a process for producing the same and a process for producing aldehydes, carboxylic acids and ketones, especially 2-keto-L-gulonic acid (hereinafter referred to as 2-KGA) utilizing said enzyme.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: June 29, 1999
    Assignee: Roche Vitamins Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino
  • Patent number: 5437989
    Abstract: A homogeneous alcohol/aldehyde dehydrogenase isolated from Gluconobacter oxydans DSM 4025 FERM BP-3812 is disclosed. The enzyme is capable in the presence of an electron acceptor, of catalyzing the conversion of L-sorbose to 2-keto-L-gulonic acid via L-sorbosone. The enzyme has a molecular weight of 130,000-140,000 daltons as determined by gel filtration column chromatography, a pyrroloquinoline quinone prosthetic group, an optimum pH for enzyme activity of 7.0 to 9.0, an optimum temperature for enzyme activity from about 20.degree. C. to 40.degree. C. and an isoelectric point of about 4.4. Also disclosed is a process for producing the enzyme and a process for producing aldehydes, carboxylic acids and ketones, especially 2-keto-L-gulonic acid utilizing the enzyme.
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: August 1, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Akira Asakura, Tatsuo Hoshino
  • Patent number: 4405408
    Abstract: A cellulose treating agent obtained by dispersing an alkyl ketene dimer in water in the presence of a dispersing agent comprising a reaction product of a polyalkylenepolyamine and a mixture of carboxylic acids containing at least 20% by weight of aliphatic monohydroxymonocarboxylic acids having 9 to 32 carbon atoms or a product obtained by reacting epihalohydrin with said reaction product. This cellulose treating agent existing as a very stable cationic aqueous dispersion of the alkyl ketene dimer is highly effective to impart a water repellency to cellulose fibers and can be used as a well-improved reactive sizing agent for papermaking.
    Type: Grant
    Filed: January 20, 1982
    Date of Patent: September 20, 1983
    Assignee: Seiko Kagaku Kogyo Co., Ltd.
    Inventors: Shigehiko Yoshioka, Hideto Yamada, Akira Asakura